Skip to main content

Advertisement

Log in

Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: The Sørreisa gastrointestinal disorder study

  • Gastro-Intestinal Diseases
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Dyspepsia and Helicobacter pylori infection are two important public health issues in the field of gastroenterology, generating high expenditures in diagnosis and treatment. A causal relationship between H. pylori and dyspepsia is still debated. The aim of this study was to address changes in the prevalence of, and association between, dyspepsia and H. pylori infection in a general population. The study took place in the municipality of Sørreisa in Northern Norway. Data were collected in 1987 and 2004. The study included questionnaires on gastrointestinal disorders and risk factors, as well as H. pylori assessment. The prevalence of dyspepsia in 2004 was 31.9% in men and 31.7% in women (compared with 30.7 and 26.3% in 1987). In 2004, the prevalence of H. pylori infection in men with/without dyspepsia was 20.3/26.7% (compared with 47.0/32.7% in 1987), whereas the prevalence of H. pylori infection in women with/without dyspepsia was 31.3/20.8% (compared with 50.0/40.7% in 1987). Since 1987, the prevalence of H. pylori has decreased independently of dyspepsia, most pronounced in the younger age groups, thus indicating a cohort effect. Our findings of a decreasing prevalence of H. pylori, a persistently high prevalence of dyspepsia, and an uneven distribution of H. pylori infection with regard to dyspepsia in men and women, question the understanding of a causal relationship between dyspepsia and H. pylori.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

ELISA:

Enzyme linked immunosorbent assay

GEE:

Generalised estimating equations

GSRS:

Gastrointestinal symptoms rating scale

H. pylori :

Helicobacter pylori

κ:

Kappa

WHO:

World Health Organisation

References

  1. Tebaldi M, Heading RC. Clinical economics review: functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther. 1998;12:11–9. doi:10.1046/j.1365-2036.1998.00261.x.

    Article  PubMed  CAS  Google Scholar 

  2. Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut. 1990;31:401–5. doi:10.1136/gut.31.4.401.

    Article  PubMed  CAS  Google Scholar 

  3. Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics. 2002;20:347–55. doi:10.2165/00019053-200220050-00006.

    Article  PubMed  Google Scholar 

  4. Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–8. doi:10.1007/BF01297451.

    Article  PubMed  CAS  Google Scholar 

  5. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:205–14. doi:10.1016/j.bpg.2006.10.005.

    Article  PubMed  Google Scholar 

  6. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65–9. doi:10.1001/jama.272.1.65.

    Google Scholar 

  7. Working IARC. Group on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.

    Google Scholar 

  8. Delaney B, Ford AC, Forman D, et al. Initial management strategies for dyspepsia. Initial management strategies for dyspepsia. Cochrane Database Syst Rev. 2005 Issue 4: CD001961.

  9. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006; issue 2: CD002096.

  10. Bernersen B, Johnsen R, Straume B, et al. Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut. 1990;31:989–92. doi:10.1136/gut.31.9.989.

    Article  PubMed  CAS  Google Scholar 

  11. Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–34. doi:10.1007/BF01535722.

    Article  PubMed  CAS  Google Scholar 

  12. Dimenas E, Glise H, Hallerback B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30:1046–52. doi:10.3109/00365529509101605.

    Article  PubMed  CAS  Google Scholar 

  13. Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut. 1996;38:822–5. doi:10.1136/gut.38.6.822.

    Article  PubMed  CAS  Google Scholar 

  14. Asfeldt AM, Lochen ML, Straume B, et al. Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection. Scand J Gastroenterol. 2004;39:1073–7. doi:10.1080/00365520410007944.

    Article  PubMed  CAS  Google Scholar 

  15. World Health Organization, Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization rates: a new who standard. GPE Discussion paper Series: No. 31: Hearings Before the SubComm. EIP/GPE/EBD of the House Comm, 2000.

  16. Bernersen B. The Sørreisa Gastrointestinal Disorder Study. Dyspepsia, peptic ulcer and endoscopic findings in a population (dissertation). Tromsø, Norway: University of Tromsø; 1996.

  17. Bernersen B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992;304:1276–9.

    Article  PubMed  CAS  Google Scholar 

  18. Lane JA, Harvey RF, Murray LJ, et al. A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: study design and response rates of the Bristol Helicobacter Project. Control Clin Trials. 2002;23:321–32. doi:10.1016/S0197-2456(01)00208-2.

    Article  PubMed  Google Scholar 

  19. Lund E, Kumle M, Braaten T, et al. External validity in a population-based national prospective study—the Norwegian Women and Cancer Study (NOWAC). Cancer Causes Control. 2003;14:1001–8. doi:10.1023/B:CACO.0000007982.18311.2e.

    Article  PubMed  Google Scholar 

  20. Banke L. Epidemiology of gastric ulcer. A preliminary study. Ugeskr Laeger. 1967;129:1705–10.

    Google Scholar 

  21. El Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643–54. doi:10.1111/j.1365-2036.2004.01897.x.

    Article  PubMed  CAS  Google Scholar 

  22. Talley NJ, Weaver AL, Tesmer DL, et al. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993;105:1378–86.

    PubMed  CAS  Google Scholar 

  23. Choung RS, Locke GR, Schleck CD, et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007;102:1983–9. doi:10.1111/j.1572-0241.2007.01381.x.

    Article  PubMed  Google Scholar 

  24. Talley NJ, Zinsmeister AR, Schleck CD, et al. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut. 1994;35:619–24. doi:10.1136/gut.35.5.619.

    Article  PubMed  CAS  Google Scholar 

  25. Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol. 2006;41:149–54. doi:10.1080/00365520510024070.

    Article  PubMed  CAS  Google Scholar 

  26. Dimenas E, Carlsson G, Glise H, et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8–13. doi:10.3109/00365529609095544.

    Article  PubMed  CAS  Google Scholar 

  27. Moayyedi P, Forman D, Braunholtz D, et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol. 2000;95:1448–55. doi:10.1111/j.1572-0241.2000.2126_1.x.

    Article  PubMed  CAS  Google Scholar 

  28. Talley NJ, Quan C. Review article: Helicobacter pylori and nonulcer dyspepsia. Aliment Pharmacol Ther. 2002;16(Suppl 1):58–65. doi:10.1046/j.1365-2036.2002.0160s1058.x.

  29. Rowland M, Daly L, Vaughan M, et al. Age-specific incidence of Helicobacter pylori. Gastroenterology. 2006;130:65–72. doi:10.1053/j.gastro.2005.11.004.

    Article  PubMed  Google Scholar 

  30. Granstrom M, Tindberg Y, Blennow M. Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol. 1997;35:468–70.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank the personnel at the Gastroenterology Unit, University Hospital of North Norway, for help in H. pylori antigen testing. The study was jointly funded by EXTRA funds from the Norwegian Foundation for Health and Rehabilitation, National Association for Digestive Diseases, Northern Norway Regional Health Authority and the University of Tromsø.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne Mette Asfeldt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asfeldt, A.M., Straume, B., Steigen, S.E. et al. Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: The Sørreisa gastrointestinal disorder study. Eur J Epidemiol 23, 625–633 (2008). https://doi.org/10.1007/s10654-008-9275-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-008-9275-x

Keywords

Navigation